Chen Shih-Chieh, Chen Wei-Chi
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung, Taiwan.
Microvasc Res. 2008 Apr;75(3):373-80. doi: 10.1016/j.mvr.2007.12.004. Epub 2008 Jan 5.
Previous studies have shown that in situ exposure to arsenic induced increased vascular leakage. However, the underlying mechanism remains unclear. Reactive nitrogen and oxygen species such as nitric oxide (NO) and hydroxyl radical (OH(-)) are known to affect vascular permeability. Therefore, the goal of our present studies is to investigate the functional impact of the generation of NO or OH(-) on arsenic-induced vascular leakage. Vascular permeability changes were evaluated by means of Evans blue (EB) assay. Rats were anesthetized and intravenously injected with EB. Permeability changes were induced in back skin by intradermal injections of sodium arsenite mixed with NOS inhibitor: N(omega)-Nitro-L-arginine methyl ester (L-NAME) or aminoguanidine (AG) and OH(-) scavenger: 1,3 Dimethyl-2 thiourea (DMTU). Experiments were also performed to determine whether DMTU mixed with L-NAME would further inhibit arsenic-induced vascular leakage as compared with attenuation effects by either DMTU or L-NAME. One hour after administration, EB accumulated in the skin was extracted and quantified. Both L-NAME (0.02, 0.1 and 0.5 micromol/site) and DMTU (0.05, 0.2 and 1.2 micromol/site) inhibited the increase in vascular leakage induced by arsenite. However, only high dose (1 micromol/site) of AG significantly attenuated arsenite-induced vascular leakage. In contrast, neither D-NAME (0.02, 0.1 and 0.5 micromol/site) nor AG (0.04 and 0.2 micromol/site) attenuated increased vascular leakage by arsenic. DMTU mixed with L-NAME caused no further inhibition of arsenic-induced vascular leakage by either DMTU or L-NAME. The techniques of India ink and immunostaining were used to demonstrate both vascular labeling and nitrotyrosine staining in tissue treated with arsenic. L-NAME apparently reduced the density of leaky vessels and the levels of peroxynitrite staining induced by arsenite. These results suggest that NO, OH(-) and peroxynitrite play a role in increased vascular permeability induced by arsenic exposure.
以往的研究表明,原位暴露于砷会导致血管渗漏增加。然而,其潜在机制仍不清楚。已知活性氮和氧物种,如一氧化氮(NO)和羟基自由基(OH(-))会影响血管通透性。因此,我们目前研究的目的是探讨NO或OH(-)的生成对砷诱导的血管渗漏的功能影响。通过伊文思蓝(EB)测定法评估血管通透性变化。将大鼠麻醉后静脉注射EB。通过皮内注射亚砷酸钠与一氧化氮合酶抑制剂:N(ω)-硝基-L-精氨酸甲酯(L-NAME)或氨基胍(AG)以及OH(-)清除剂:1,3-二甲基-2-硫脲(DMTU),在背部皮肤诱导通透性变化。还进行了实验,以确定与DMTU或L-NAME单独的减弱作用相比,DMTU与L-NAME混合是否会进一步抑制砷诱导的血管渗漏。给药1小时后,提取并定量皮肤中积累的EB。L-NAME(0.02、0.1和0.5微摩尔/部位)和DMTU(0.05、0.2和1.2微摩尔/部位)均抑制了亚砷酸盐诱导的血管渗漏增加。然而,只有高剂量(1微摩尔/部位)的AG能显著减弱亚砷酸盐诱导的血管渗漏。相比之下,D-NAME(0.02、0.1和0.5微摩尔/部位)和AG(0.04和0.2微摩尔/部位)均未减弱砷引起的血管渗漏增加。DMTU与L-NAME混合并没有通过DMTU或L-NAME进一步抑制砷诱导的血管渗漏。使用印度墨汁和免疫染色技术来显示用砷处理的组织中的血管标记和硝基酪氨酸染色。L-NAME明显降低了渗漏血管的密度以及亚砷酸盐诱导的过氧亚硝酸盐染色水平。这些结果表明,NO、OH(-)和过氧亚硝酸盐在砷暴露诱导的血管通透性增加中起作用。